Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system

Pflugers Archiv European Journal of Physiology

Volumn 467, Issue 12, 2015, Pages 2413-2421

  Muller, Marie Eve ^a   Forni Ogna, Valentina ^a   Maillard, Marc ^a   Stoudmann, Candice ^b   Zweiacker, Carole ^a   Anex, Christiane ^a   Wuerzner, Grégoire ^a   Burnier, Michel ^a   Bonny, Olivier ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Calcium sensing receptor; Cinacalcet; Furosemide; Mineral metabolism; Renin angiotensin aldosterone system

Indexed keywords

ALDOSTERONE; CALCIUM; CALCIUM SENSING RECEPTOR; CINACALCET; FUROSEMIDE; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE; PLACEBO; POTASSIUM; RENIN; SODIUM; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 1; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 2; CALCIMIMETIC AGENT; DIURETIC AGENT; SLC12A1 PROTEIN, HUMAN; SLC12A2 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSSOVER PROCEDURE; ELECTROLYTE URINE LEVEL; HUMAN; HUMAN TISSUE; INGESTION; LIMIT OF QUANTITATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE DRUG DOSE; URINARY EXCRETION; ADOLESCENT; BLOOD; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; PARATHYROID GLAND;

ADOLESCENT; ADULT; ALDOSTERONE; CALCIMIMETIC AGENTS; CALCIUM; CINACALCET HYDROCHLORIDE; DIURETICS; FEMALE; FUROSEMIDE; HUMANS; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROID HORMONE; RECEPTORS, CALCIUM-SENSING; RENIN; RENIN-ANGIOTENSIN SYSTEM; SOLUTE CARRIER FAMILY 12, MEMBER 1; SOLUTE CARRIER FAMILY 12, MEMBER 2;

EID: 84947495049     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-015-1714-4     Document Type: Article

References (31)

1. Brown EM, Jones P, Adragna N (1983) Effects of ouabain on [3H]ouabain binding, 86Rb uptake, cellular sodium and potassium, and parathyroid hormone secretion in dispersed bovine parathyroid cells. Endocrinology 113(1):371–378
2. Brown EM, Watson EJ, Thatcher JG, Koletsky R, Dawson-Hughes BF, Posillico JT, Shoback DM (1987) Ouabain and low extracellular potassium inhibit PTH secretion from bovine parathyroid cells by a mechanism that does not involve increases in the cytosolic calcium concentration. Metab Clin Exp 36(1):36–42
3. Brown JM, Williams JS, Luther JM, Garg R, Garza AE, Pojoga LH, Ruan DT, Williams GH, Adler GK, Vaidya A (2014) Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone. Hypertension 63(2):273–280. doi:10.1161/HYPERTENSIONAHA.113.01910
4. Brunaud L, Germain A, Zarnegar R, Rancier M, Alrasheedi S, Caillard C, Ayav A, Weryha G, Mirallie E, Bresler L (2009) Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism. Surgery 146(6):1035–1041. doi:10.1016/j.surg.2009.09.041
5. Castrop H, Lorenz JN, Hansen PB, Friis U, Mizel D, Oppermann M, Jensen BL, Briggs J, Skott O, Schnermann J (2005) Contribution of the basolateral isoform of the Na-K-2Cl- cotransporter (NKCC1/BSC2) to renin secretion. Am J Physiol Ren Physiol 289(6):F1185–F1192. doi:10.1152/ajprenal.00455.2004
6. Coe FL, Canterbury JM, Firpo JJ, Reiss E (1973) Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest 52(1):134–142. doi:10.1172/JCI107156
7. el-Hajj Fuleihan G, Klerman EB, Brown EN, Choe Y, Brown EM, Czeisler CA (1997) The parathyroid hormone circadian rhythm is truly endogenous—a general clinical research center study. J Clin Endocrinol Metab 82(1):281–286
8. Elmgreen J, Tougaard L, Leth A, Christensen MS (1980) Elevated serum parathyroid hormone concentration during treatment with high ceiling diuretics. Eur J Clin Pharmacol 18(4):363–364
9. Fischer E, Hannemann A, Rettig R, Lieb W, Nauck M, Pallauf A, Bildingmaier M, Beuschlein F, Wallaschofski H, Reincke M (2014) A high aldosterone to renin ratio is associated with high serum parathyroid hormone concentrations in the general population. J Clin Endocrinol Metab 99(3):965–971. doi:10.1210/jc.2013-3214
10. Fujita T, Chan JC, Bartter FC (1984) Effects of oral furosemide and salt loading on parathyroid function in normal subjects. Physiological basis for renal hypercalciuria. Nephron 38(2):109–114
11. Grant FD, Mandel SJ, Brown EM, Williams GH, Seely EW (1992) Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J Clin Endocrinol Metab 75(4):988–992
12. Haegeli L, Brunner-La Rocca HP, Wenk M, Pfisterer M, Drewe J, Krahenbuhl S (2007) Sublingual administration of furosemide: new application of an old drug. Br J Clin Pharmacol 64(6):804–809. doi:10.1111/j.1365-2125.2007.03035.x
13. Hufnagle KG, Khan SN, Penn D, Cacciarelli A, Williams P (1982) Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Pediatrics 70(3):360–363
14. Imura A, Tsuji Y, Murata M, Maeda R, Kubota K, Iwano A, Obuse C, Togashi K, Tominaga M, Kita N, Tomiyama K, Iijima J, Nabeshima Y, Fujioka M, Asato R, Tanaka S, Kojima K, Ito J, Nozaki K, Hashimoto N, Ito T, Nishio T, Uchiyama T, Fujimori T, Nabeshima Y (2007) alpha-Klotho as a regulator of calcium homeostasis. Science 316(5831):1615–1618. doi:10.1126/science.1135901
15. Isales CM, Barrett PQ, Brines M, Bollag W, Rasmussen H (1991) Parathyroid hormone modulates angiotensin II-induced aldosterone secretion from the adrenal glomerulosa cell. Endocrinology 129(1):489–495. doi:10.1210/endo-129-1-489
16. Jespersen B, Pedersen EB, Charles P, Danielsen H, Juhl H (1989) Elevated angiotensin II and vasopressin in primary hyperparathyroidism. Angiotensin II infusion studies before and after removal of the parathyroid adenoma. Acta Endocrinol (Copenh) 120(3):362–368
17. Kim YG, Kim B, Kim MK, Chung SJ, Han HJ, Ryu JA, Lee YH, Lee KB, Lee JY, Huh W, Oh HY (2001) Medullary nephrocalcinosis associated with long-term furosemide abuse in adults. Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc - Eur Ren Assoc 16(12):2303–2309
18. Maillard MP, Tedjani A, Perregaux C, Burnier M (2009) Calcium-sensing receptors modulate renin release in vivo and in vitro in the rat. J Hypertens 27(10):1980–1987. doi:10.1097/HJH.0b013e32832f0d22
19. Maniero C, Fassina A, Guzzardo V, Lenzini L, Amadori G, Pelizzo MR, Gomez-Sanchez C, Rossi GP (2011) Primary hyperparathyroidism with concurrent primary aldosteronism. Hypertension 58(3):341–346. doi:10.1161/HYPERTENSIONAHA.111.173948
20. Maniero C, Fassina A, Seccia TM, Toniato A, Iacobone M, Plebani M, De Caro R, Calo LA, Pessina AC, Rossi GP (2012) Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism. J Hypertens 30(2):390–395. doi:10.1097/HJH.0b013e32834f0451
21. Martuseviciene G, Hofman-Bang J, Clausen T, Olgaard K, Lewin E (2011) The secretory response of parathyroid hormone to acute hypocalcemia in vivo is independent of parathyroid glandular sodium/potassium-ATPase activity. Kidney Int 79(7):742–748. doi:10.1038/ki.2010.501
22. Mazzocchi G, Aragona F, Malendowicz LK, Nussdorfer GG (2001) PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells. Am J Physiol Endocrinol Metab 280(2):E209–E213
23. Ortiz-Capisano MC, Ortiz PA, Garvin JL, Harding P, Beierwaltes WH (2007) Expression and function of the calcium-sensing receptor in juxtaglomerular cells. Hypertension 50(4):737–743. doi:10.1161/HYPERTENSIONAHA.107.095158
24. Osorio AV, Alon MM, Nichols MA, Alon US (1998) Effect of age on furosemide-induced nephrocalcinosis in the rat. Biol Neonate 73(5):306–312
25. Pattaragarn A, Fox J, Alon US (2004) Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat. Kidney Int 65(5):1684–1689. doi:10.1111/j.1523-1755.2004.00564.x
26. Pirklbauer M, Mayer G (2011) The exchangeable calcium pool: physiology and pathophysiology in chronic kidney disease. Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc - Eur Ren Assoc 26(8):2438–2444. doi:10.1093/ndt/gfr207
27. Reichel H, Deibert B, Geberth S, Schmidt-Gayk H, Ritz E (1992) Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency. Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc - Eur Ren Assoc 7(1):8–15
28. Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L (2001) Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women. Eur J Clin Investig 31(9):764–772
29. Rosenberg J, Pines M, Hurwitz S (1987) Response of adrenal cells to parathyroid hormone stimulation. J Endocrinol 112(3):431–437
30. Saarela T, Lanning P, Koivisto M, Paavilainen T (1999) Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up. Eur J Pediatr 158(8):668–672
31. Stote RM, Smith LH, Wilson DM, Dube WJ, Goldsmith RS, Arnaud CD (1972) Hydrochlorothiazide effects on serum calcim and immunoreactive parathyroid hormone concentrations. Studies in normal subjects. Ann Intern Med 77(4):587–591